Contact us (is on the right)

  1. Company
    1. About
    2. Services
  2. Media
    1. News blog
    2. Meet GCT team
  3. White papers
    1. Region and countries
    2. Therapeutic areas
  4. Services
    1. Site registration
    2. Patient information Center
  5. Website information
    1. Privacy policy
    2. Terms of service
    3. Site map
    4. Employees login

Get in touch

Call us:

Email: info@gctrials.com

Meet us at upcoming industry events

More: Offices, Career at GCT

Patients: Patient information Center

Oncology

GCT has solid experience in Oncology (see some examples in the table below). We know the sites which count hundreds in the region. GCT has established close relations with key opinion leaders in oncology and is ready to recommend you the best combination in terms of recruitment speed and local regulations, geography and logistics, experience and costs (PI and site fees), equipment (CT/MRI, PET, radiology department, etc.) and standards of treatment applied.

Phase# Pnts# SitesCountriesIndicationSponsor
III206UkraineNon-Hodgkin's lymphomaRussian biotech
III/IV358UkraineBreast CancerUS biopharma
IV503RussiaAdvanced prostate cancerNPO
II4015RussiaProstate CancerEU Pharma
IIb5113RussiaProstate CancerEU Pharma
III16012RussiaChemotherapy-induced nausea and vomitingUK pharma
III805RussiaMetastatic Breast CancerNPO
II672RussiaBreast CancerNPO
IIb37012RussiaProstate CancerEU Pharma
I/BE4510UkraineOvarian cancer, fallopian tube and primary peritoneal cancersUS Pharma
II/III1111RussiaMetastatic Breast CancerRussian biotech
IIa7513RussiaAdvanced Solid TumorsUS Biotech

Hundreds of Phase I-IV ICH-GCP international cancer- treatment clinical trials are conducted in Russia, Ukraine, Romania and Bulgaria annually. Oncology clinical research projects rank in the first place among all therapeutic areas in the region ranging from 15% to 25% in share. In the region with the total population around 220m and with the centralized healthcare system patients’ recruitment potential, including treatment-naive subjects, is enormous, which is especially attractive for late-stage international clinical research projects.

oncology_dia

 

The quality of clinical research data coming from Russia and CEE region is comparatively high. For example, the percentage of FDA/EMA approved drugs studied within international clinical trials placed in part in Russia is increasing (29% in 2010, 33% in 2011, 37% in 2012, and 65% in 2013). As per the EMA report of 08-Apr-2013, Russia is among five top-enrolling countries in clinical research worldwide. Moreover, including Russia into your clinical study, you escape the need to conduct local registration clinical studies in future and save time and costs to launch to the Russian market!

More information

We will be happy to provide more information about Oncology studies in CEE and Russia. Please contact us or simply use the form below. A representative will respond shortly.




I have read, understood and agreed to Terms of Service and Privacy Policy. I agree to be contacted by a GCT representative.